Literature DB >> 34193069

Increased Vδ1γδT cells predominantly contributed to IL-17 production in the development of adult human post-infectious irritable bowel syndrome.

L W Dong1, X N Sun1, Z C Ma1, J Fu1, F J Liu1, B L Huang1, D C Liang1, D M Sun2, Cheng Lan3.   

Abstract

BACKGROUND: γδT cells play an important role in the mucosa inflammation and immunity-associated disorders. Our previous study reported that γδ T cells producing IL-17 were involved in the pathogenesis of post-infectious irritable bowel syndrome (PI-IBS). However, their subset characteristic profile in this kind of disease remains unclear. Thus the current study's aim is to investigate the functionally predominant subset and its role in PI-IBS.
METHODS: The total T cells were collected from the peripheral blood of patients with PI-IBS. The peripheral proportion of Vδ1 and Vδ2 subset was detected by FACS after stained with anti δ1-PE and anti δ2-APC. The local colonic proportion of this two subsets were measured under laser confocal fluorescence microscope. Vδ1 γδ T cells were enriched from the total peripheral T cells by minoantibody-immuno-microbeads (MACS) method and cultured, functionally evaluated by CCK-8 assay (proliferation), CD69/CD62L molecules expression assay (activation) and ELISA (IL-17 production) respectively.
RESULTS: 1. Vδ1 γδ T cells significantly increased while Vδ2 γδ T cells remained unchanged in both the peripheral blood and local colonic tissue from PI-IBS patients (p < 0.05). 2. When cultured in vitro, the Vδ1 γδ T cells remarkably proliferated, activated and produced IL-17 (p < 0.05).
CONCLUSIONS: Our results suggest that Vδ1 γδ T cells was the predominant γδ T cells subset in both peripheral and intestinal tissue, and was the major IL-17 producing γδ T cells in PI-IBS.

Entities:  

Keywords:  Function; Pathogenesis; Post-infectious irritable bowel syndrome; Subset; Γδ T cells

Year:  2021        PMID: 34193069     DOI: 10.1186/s12876-021-01722-8

Source DB:  PubMed          Journal:  BMC Gastroenterol        ISSN: 1471-230X            Impact factor:   3.067


  6 in total

1.  Abnormal immune regulation and low-grade inflammation in IBS: does one size fit all?

Authors:  Max Schmulson; William D Chey
Journal:  Am J Gastroenterol       Date:  2012-02       Impact factor: 10.864

Review 2.  Rome III: New standard for functional gastrointestinal disorders.

Authors:  Douglas A Drossman; Dan L Dumitrascu
Journal:  J Gastrointestin Liver Dis       Date:  2006-09       Impact factor: 2.008

3.  Decreased expression of microRNA-510 in intestinal tissue contributes to post-infectious irritable bowel syndrome via targeting PRDX1.

Authors:  Yu Zhang; Xiaxin Wu; Jinfeng Wu; Shuang Li; Sen Han; Zhijie Lin; Shizhen Ding; Xiaoqin Jia; Weijuan Gong
Journal:  Am J Transl Res       Date:  2019-12-15       Impact factor: 4.060

4.  Aberrant mucosal lymphocyte number and subsets in the colon of post-infectious irritable bowel syndrome patients.

Authors:  Johanna Sundin; Ignacio Rangel; Ashok K Kumawat; Elisabeth Hultgren-Hörnquist; Robert J Brummer
Journal:  Scand J Gastroenterol       Date:  2014-06-12       Impact factor: 2.423

5.  Beneficial effects of Rifaximin in post-infectious irritable bowel syndrome mouse model beyond gut microbiota.

Authors:  Yu Jin; Xiaoyang Ren; Gangping Li; Ying Li; Lei Zhang; Huan Wang; Wei Qian; Xiaohua Hou
Journal:  J Gastroenterol Hepatol       Date:  2018-02       Impact factor: 4.029

6.  A Novel EphA2 Inhibitor Exerts Beneficial Effects in PI-IBS in Vivo and in Vitro Models via Nrf2 and NF-κB Signaling Pathways.

Authors:  Li Zeng; Kaixue Li; Hong Wei; Jingjing Hu; Lu Jiao; Shaoyong Yu; Ying Xiong
Journal:  Front Pharmacol       Date:  2018-03-27       Impact factor: 5.810

  6 in total
  2 in total

1.  Overlap between irritable bowel syndrome and common gastrointestinal diagnoses: a retrospective cohort study of 29,553 outpatients in Germany.

Authors:  Sven H Loosen; Karel Kostev; Tom Luedde; Christoph Roderburg; Markus S Jördens
Journal:  BMC Gastroenterol       Date:  2022-02-05       Impact factor: 3.067

Review 2.  Regulation of CD4+ and CD8+ T Cell Biology by Short-Chain Fatty Acids and Its Relevance for Autoimmune Pathology.

Authors:  Carmen Schiweck; Sharmili Edwin Thanarajah; Mareike Aichholzer; Silke Matura; Andreas Reif; Elske Vrieze; Andreas Weigert; Alexander Visekruna
Journal:  Int J Mol Sci       Date:  2022-07-27       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.